The continuing spread of for-profit clinics promoting stem cells and other so-called “regenerative” therapies — including concentrated blood products — illustrates how quickly experimental medicine can outpace government oversight.
from Section Page News - Modern Healthcare https://ift.tt/3F2Yztz
